Predictors of Recurrence After Resection of Small Gastric Gastrointestinal Stromal Tumors of 5 cm or Less

被引:34
作者
Kim, Mi-Young [1 ]
Park, Young Soo [2 ]
Choi, Kee Don [1 ]
Lee, Jeong Hoon [1 ]
Choi, Kwi-Sook [1 ]
Kim, Do Hoon [1 ]
Song, Ho June [1 ]
Lee, Gin Hyug [1 ]
Jung, Hwoon-Yong [1 ]
Kim, Jin-Ho [1 ]
Yun, Sung-Cheol [5 ]
Kim, Kab Choong [3 ]
Yook, Jeong Hwan [3 ]
Oh, Sung Tae [3 ]
Kim, Byung Sik [3 ]
Ryu, Min-Hee [4 ]
Kang, Yoon-Koo [4 ]
机构
[1] Univ Ulsan, Coll Med, Dept Gastroenterol, Asan Med Ctr,Asan Digest Dis Res Inst, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Dept Surg, Asan Med Ctr, Seoul 138736, South Korea
[4] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul 138736, South Korea
[5] Univ Ulsan, Coll Med, Div Biostat, Ctr Med Res & Informat, Seoul 138736, South Korea
关键词
gastrointestinal stromal tumors; stomach; prognosis; mitotic index; p53; PORT-SITE METASTASIS; LAPAROSCOPIC RESECTION; PROGNOSTIC-FACTORS; IMATINIB MESYLATE; POOR-PROGNOSIS; MANAGEMENT; ASSOCIATION; EXPRESSION; PATHOLOGY; STRATEGY;
D O I
10.1097/MCG.0b013e31821f8bf6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goals: To evaluate the recurrence predicting factors of small gastric gastrointestinal stromal tumors (GISTs) through the long-term follow-up after surgical/endoscopic resection. Background: Although small gastric GISTs are known to have a low risk of recurrence after complete resection, the prognostic factors are not well known. Study: The study retrospectively analyzed the records of 136 patients with primary gastric GISTs of 5 cm or less without metastasis who underwent surgical/endoscopic resection between March 1997 and December 2008 at the Asan Medical Center, and who were followed-up for at least 3 months after resection. Specimens were assessed for tumor size, mitotic index, and microscopic resection margin. Specimen sections were immunohistochemically stained to determine the levels of expression of the cell cycle proteins p53, p16(INK4), pRb, cyclin D1, and Ki-67. DNA was extracted from high-risk tumors to analyze for KIT mutations. Results: Among 136 patients, 5 (3.7%) patients with tumors with a high mitotic index showed recurrence at a median 23 months post resection. None of 14 patients with microscopic positive resection margins showed recurrence during a median follow-up time of 32 months. A high mitotic index was a predictor of recurrence (P < 0.001), but that tumor size, method of resection, or margin status were not. In addition, abnormal p53 expression was found to be associated with recurrence (P = 0.004). All assessable high-risk tumors had a KIT exon 11 mutation. Conclusions: Predictors of recurrence of gastric GISTs of 5 cm or less were a high mitotic index and abnormal p53 expression. A positive microscopic resection margin was not associated with recurrence.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 39 条
  • [1] Antonescu CR, 2003, CLIN CANCER RES, V9, P3329
  • [2] Aoyagi K, 2009, INT SURG, V94, P1
  • [3] Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
    Choi, Haesun
    Charnsangavej, Chuslip
    Faria, Silvana C.
    Macapinlac, Homer A.
    Burgess, Michael A.
    Patel, Shreyaskumar R.
    Chen, Lei L.
    Podoloff, Donald A.
    Benjamin, Robert S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1753 - 1759
  • [4] Critical issues in response evaluation on computed tomography: Lessons from the gastrointestinal stromal tumor model
    Choi H.
    [J]. Current Oncology Reports, 2005, 7 (4) : 307 - 311
  • [5] Port site metastasis following diagnostic laparoscopy for a malignant Gastro-intestinal stromal tumour
    Davies, Andrew R.
    Ahmed, Waseem
    Purkiss, Shaun F.
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
  • [6] Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
    DeMatteo, Ronald P.
    Gold, Jason S.
    Saran, Lisa
    Goenen, Mithat
    Liau, Kui Hin
    Maki, Robert G.
    Singer, Samuel
    Besmer, Peter
    Brennan, Murray F.
    Antonescu, Cristina R.
    [J]. CANCER, 2008, 112 (03) : 608 - 615
  • [7] Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
    DeMatteo, Ronald P.
    Ballman, Karla V.
    Antonescu, Cristina R.
    Maki, Robert G.
    Pisters, Peter W. T.
    Demetri, George D.
    Blackstein, Martin E.
    Blanke, Charles D.
    von Mehren, Margaret
    Brennan, Murray F.
    Patel, Shreyaskumar
    McCarter, Martin D.
    Polikoff, Jonathan A.
    Tan, Benjamin R.
    Owzar, Kouros
    [J]. LANCET, 2009, 373 (9669) : 1097 - 1104
  • [8] Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival
    DeMatteo, RP
    Lewis, JJ
    Leung, D
    Mudan, SS
    Woodruff, JM
    Brennan, MF
    [J]. ANNALS OF SURGERY, 2000, 231 (01) : 51 - 58
  • [9] Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1
  • [10] Prognosis of gastrointestinal smooth-muscle (Stromal) tumors - Dependence on anatomic site
    Emory, TS
    Sobin, LH
    Lukes, L
    Lee, DH
    O'Leary, TJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (01) : 82 - 87